Jamieson Wellness (OTCMKTS:JWLLF – Get Free Report) is projected to issue its results after the market closes on Thursday, November 5th. Analysts expect the company to announce earnings of $0.3464 per share and revenue of $157.61 million for the quarter.
Jamieson Wellness Stock Performance
Jamieson Wellness stock opened at $32.55 on Tuesday. The stock’s fifty day moving average price is $32.43 and its two-hundred day moving average price is $28.21. Jamieson Wellness has a one year low of $23.88 and a one year high of $33.15.
Analyst Upgrades and Downgrades
A number of research firms have recently weighed in on JWLLF. Citigroup downgraded Jamieson Wellness to a “hold” rating in a research report on Friday, August 7th. TD Securities cut Jamieson Wellness from a “buy” rating to a “sell” rating in a research report on Thursday, October 1st. Finally, Royal Bank Of Canada cut Jamieson Wellness from an “outperform” rating to a “sector perform” rating in a research report on Monday, August 10th. Two investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.
Check Out Our Latest Stock Report on Jamieson Wellness
About Jamieson Wellness
Jamieson Wellness Inc is a Canadian consumer health company that develops, manufactures and distributes vitamins, minerals and supplements. Its products are designed to support areas such as general wellness, immunity, digestion, nutrition and sports performance, and are sold through pharmacies, grocery stores, mass retailers, specialty health outlets and e-commerce channels.
The company’s portfolio includes the Jamieson brand, which offers vitamins, minerals, herbal products and other nutritional supplements.
Further Reading
- Five stocks we like better than Jamieson Wellness
- AST SpaceMobile’s Brazil Breakthrough Could Set the Stage for a Q3 Stock Rebound
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.
